Literature DB >> 30626182

Activity-Based Near-Infrared Fluorogenic Probe for Enabling in Vitro and in Vivo Profiling of Neutrophil Elastase.

Shi-Yu Liu1, Hao Xiong1, Rong-Rong Li1, Wen-Chao Yang1, Guang-Fu Yang1,2.   

Abstract

Neutrophil elastase (NE), a typical hematopoietic serine protease, has significant roles in inflammatory and immune responses, and thus is highly associated with various diseases such as acute lung injury (ALI) and lung cancer. Rapid and accurate measurement of NE activity in biological systems is particularly important for understanding the role of NE in inflammatory diseases, as well as clinical diagnosis. However, the specific detection and noninvasive imaging of NE in vivo remains a challenge. To address this issue, a small-molecule substrate based near-infrared fluorogenic probe (NEP) for NE was constructed via incorporating pentafluoroethyl as the recognition group with a hemicyanine dye-based fluorophore. This initially quenched probe possesses more than 25-fold red fluorescence enhancement upon the catalysis of human NE, and the detection limit is about 29.6 ng/mL. In addition, the high specificity and the long emission wavelength (λemmax = 700 nm) of NEP allowed the direct monitoring of NE-trafficking, exogenous NE uptake, and endogenous NE upregulation at the cellular level. Moreover, the successful spatiotemporal imaging of NE in ALI model mice also made it a promising new tool in clinical diagnosis for ALI and other lung diseases.

Entities:  

Year:  2019        PMID: 30626182     DOI: 10.1021/acs.analchem.8b04455

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  2 in total

Review 1.  Activity-Based Probes to Utilize the Proteolytic Activity of Cathepsin G in Biological Samples.

Authors:  Timo Burster; Fabian Gärtner; Uwe Knippschild; Anuar Zhanapiya
Journal:  Front Chem       Date:  2021-02-25       Impact factor: 5.221

2.  ZWZ-3, a Fluorescent Probe Targeting Mitochondria for Melanoma Imaging and Therapy.

Authors:  Zengjin Liu; Hailan Wang; Changzhen Sun; Yuanmin He; Tong Xia; Jianv Wang; Xia Xiong; Qingbi Zhang; Sijin Yang; Li Liu
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.